产品介绍：
产品说明
一般描述
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
应用
在血红蛋白和过氧化物酶的微量测定中替代联苯胺、邻联茴香胺和邻联甲苯胺。
生化/生理作用
氯丙嗪表现出对白血病细胞的细胞毒性和抗增殖活性，但是不会影响正常淋巴细胞的活力。
吩噻嗪类抗精神病药;D2 多巴胺受体拮抗剂，H1 组胺受体拮抗剂;抑制钙调蛋白依赖性环核苷酸磷酸二酯酶和一氧化氮合成酶的活化。
包装
Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
其他说明
Sales restrictions may apply.
基本信息
| 经验(实验)分子式 | C17H19ClN2S · HCl |
| 分子量 | 355.33 |
| Beilstein | 3779989 |
| MDL编号 | MFCD00012654 |
产品性质
| 等级 | pharmaceutical primary standard |
| manufacturer/tradename | BP |
| 格式 | neat |
| 储存温度 | 2-8℃ |
| SMILES string | Cl[H].CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13 |
| InChI | 1S/C17H19ClN2S.ClH/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20;/h3-4,6-9,12H,5,10-11H2,1-2H3;1H |
| InChI key | FBSMERQALIEGJT-UHFFFAOYSA-N |
| Gene Information | human ... DRD2(1813), DRD3(1814), DRD4(1815), HTR2A(3356) |
安全信息
| 象形图 |  |
| 警示用语： | Danger |
| 危险声明 | H301 - H330 |
| 预防措施声明 | P260 - P264 - P270 - P271 - P284 - P304 + P340 + P310 |
| 危险分类 | Acute Tox. 1 Inhalation - Acute Tox. 3 Oral |
| 储存分类代码 | 6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
